HOXB13 and neoplasm: Our data reveal SLC12A5 could bind with YTHDC1 to form a SLC12A5-YTHDC1 complex to regulate prostate cancer specific transcription factor HOXB13 in an m6A-dependent manner, uncovering a novel mechanism about how SLC12A5 promotes tumor progression.